Li, J., Chiu, K., Wang, S., Yang, C., Chen, C., Ho, H., . . . Ou, Y. (2017). Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel. Front Pharmacol.
Citación estilo ChicagoLi, Jian-Ri, et al. "Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients After Docetaxel." Front Pharmacol 2017.
Cita MLALi, Jian-Ri, et al. "Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients After Docetaxel." Front Pharmacol 2017.